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النتائج السريرية ومشاكل املشورة ملتالزمة التثلث الصبغي اجلزئي لطرف 
صبغ Xp يف طفل مصاب بتأخر التطور.
كارين ل. �شيث، روبرتو ل مازا�شى، �شامل اأفتيمو�ض، نريين جريجر�شن، األي�ض م جورج، دونالد ر. لوف
امللخ�ص: متثل الن�شاء حاملى الأزفاء ال�شبغي املتوازن املحتوى على �شبغ X و�شبغ ج�شدي حتديا كبريا يف امل�شورة الوراثية نظرا للعديد 
من الحتمالت النت�شافية واأي�شا نتيجة لتاأثري اجلينات املتمركزة على ال�شبغ X التي قد ل تخ�شع لعملية التعطيل. هذا تقرير حالة 
النووي اجلزيئي قد تقدم  التنميط  X على م�شتق ال�شبغ اجل�شدي با�شتخدام  اإظهار مدى تاأثر اجلينات املتمركزة على ال�شبغ  اأن  يو�شح 
معلومات قاطعة يف �شياق امل�شورة الوراثية.
للجا�شرتين؛ املفرز  الببتيد  امل�شتقبالت؛  اأك�ض؛  ال�شبغ  تعطيل  Xp22؛  ال�شبغي  الإحاد  X؛  �شبغ  ال�شبغي؛  التثلث  الكلمات:   مفتاح 
بروتني ك اأ ل – 1؛ تقرير حالة؛ نيوزيالند.
abstract: Female carriers of balanced translocations involving an X chromosome and an autosome offer genetic 
counselling challenges. This is in view of the number of possible meiotic outcomes, but also due to the impact of X 
chromosome-localised genes that are no longer subject to gene silencing through the X chromosome inactivation 
centre. We present a case where delineation of the extent of X chromosome-localised genes on the derivative 
autosome using molecular karyotyping offers critical information in the context of genetic counselling.
Keywords: Trisomy; X chromosome, monosomy Xp22 pter; X chromosome inactivation; Receptors, gastrin-
releasing peptide; KAL-1 protein; Case report; New Zealand.
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Case report
Female carriers of balanced translocations between an X chromosome and an autosome can exhibit a range of 
phenotypes from apparently normal to those 
with a range of abnormalities.1 This outcome is 
due almost entirely to a skewed X inactivation 
pattern. In phenotypically normal females, the 
translocated X is preferentially activated and 
the intact X is inactivated. From a counselling 
perspective, this presents problems. There are many 
possible genotypic outcomes for the  offspring of a 
balanced carrier and, unlike an autosome-autosome 
translocation, there is the added complication 
of estimating risk when there is the possibility of 
functional disomy.
Functional disomy occurs when the translocated 
portion of the X chromosome is separated from 
the X chromosome inactivation centre located 
at Xq13.,2 and is therefore unable to undergo X 
chromosome-based inactivation. About 30% of 
genes on the short arm of the X chromosome 
escape X chromosome inactivation and continue 
to be expressed from the inactive X chromosomes.2 
This is true even in females with trisomy X; the 
increased dosage is unlikely to have any deleterious 
effect, as most trisomy X females are phenotypically 
normal.2 From this we can assume that an 
abnormal phenotype is the result of the expression 
of duplicated genes, normally silenced during X 
chromosome inactivation.
Previously reported cases of functional disomy 
for chromosome Xp vary substantially both from the 
extent of the p-arm that is involved and the severity 
of the phenotype. Not surprisingly, those patients 
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who have all (or almost all) of the Xp arm exhibit 
more severe phenotypic features.3–5 Those with 
smaller regions of functional Xp disomy generally 
exhibit a less severe phenotype.6–9 A comparison of 
the phenotypic features of these cases is shown in 
Table 1.
Here we describe a case of a maternally inherited 
17 Mb duplication of Xp22.33p22.13 detected by 
molecular karyotype in a 17-month-old female 
infant. G-banding analysis of the mother and the 
molecular karyotype data of the proband led to a 
deduced karyotype of the proband. The molecular 
karyotype data also allowed for a more informed 
discussion of the implications of future pregnancies 
for the mother.
Case Report
The 3 Kg proband was born at term to non-
consanguineous parents. At delivery, her mother 
and father were 29 and 34 years old, respectively. 
There was no history of recurrent miscarriages, 
stillbirths, neonatal deaths, or individuals with 
intellectual disability and/or unusual physical 
features.
Poor growth was observed during the last 4 
weeks of pregnancy and the mother noted reduced 
fetal movements compared to her first pregnancy. 
During the first year of life, the proband’s length 
followed the 50th centile and her weight the 10th 
centile. She sat at 5 months of age but did not crawl 
until 15 months. Repeated significant respiratory 
infections and minimal weight gain prompted a 
hospital admission at 17 months of age. At that 
time, she was pulling to stand but not walking. She 
was babbling and waving “bye-bye” appropriately. 
She could point to objects, was developing a pincer 
grip in both hands, and had a vocabulary of 7 words.
A genetic assessment at that time noted 
a head circumference at the 10th centile, mild 
brachycephaly, and a flat bridge of the nose in 
the absence of telecanthus or hypertelorism. In 
view of the history of unexplained growth and 
developmental retardation, a molecular karyotype 
was requested. 
Radiology revealed the presence of right upper 
and lower lobe pneumonia for which she received 
appropriate antibiotic treatment and fully recovered. 
No underlying anatomic or immune abnormalities 
were identified to explain her repeated respiratory 
infections and she had no further infections over 
the ensuing months.
A molecular karyotype analysis was performed 
on extracted deoxyribonucleic acid (DNA) using the 
Affymetrix® Cytogenetics Whole-Genome 2.7M 
Array (Affymetrix, Santa Clara, California, USA). 
Regions of copy number change were calculated 
using the Affymetrix® Chromosome Analysis Suite 
software (ChAS) v.1.0.1 which was interpreted with 
the aid of the University of California Santa Cruz 
genome browser (hg18 assembly).10 The proband’s 
molecular karyotype identified an extra copy of the 
17.2 Mb terminal region of the X chromosome; arr 
Xp22.33p22.13(125,959-17,372,584)x3.
Conventional G-banded chromosome analysis 
was performed on peripheral blood samples taken 
from the proband’s mother, which showed an 
abnormal female karyotype with an apparently 
balanced translocation between the short arm 
of one X chromosome and the short arm of 
chromosome 13; 46,X,t(X;13)(p22.13;p11.2). 
Conventional G-banded chromosome analysis on 
blood samples from the mother’s parents showed 
normal karyotypes, confirming that the balanced 
translocation in the mother was a de novo event.
Discussion
Due to the uncertain nature of X chromosome 
inactivation (and prenatal inactivation studies may 
not be predictive of phenotype), a balanced female 
chromosome complement identified at prenatal 
diagnosis is not necessarily associated with a 
normal phenotype, and some abnormal outcomes 
may not give rise to a significant abnormality. 
Male X-autosome translocation carriers have 
been recorded previously with normal and 
abnormal phenotypes. Consequently, a detailed 
fetal ultrasound examination is recommended. 
The estimated overall risk for liveborn offspring 
with structural and/or functional imbalance is 
difficult to estimate but would be in the region of 
20–40%.11 The risk of fetal loss is also likely to 
increase compared to the general population’s 
risk of 15%.11 Critically, prenatal diagnosis should 
be available, and unbalanced products of the 
translocation would be detectable on cultured 
chorionic villus cells or amniocytes.
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The duplicated maternal X chromosome region 
of 17 Mb reported in the proband contains numerous 
genes. The genes within the pseudoautosomal region 
(PAR1), which encompasses approximately 2.7 Mb 
of the terminal short arm of the X chromosome 
and comprising 24 genes, obviously escape X 
inactivation.12 Escape genes are often clustered with 
as many as 13 genes in large domains ranging in size 
between 100 Kb and 7 Mb. Interestingly, recent data 
suggest that those X-linked genes that apparently 
escape inactivation as determined by somatic cell 
hybrid data may exhibit monoallelic expression, or 
expression at levels that may be as low as 25% of the 
same gene on an active X chromosome.13,14



























Xp21.1→pter Xp11.21p21.3 Xp11.2p22.23 Xp11.2→pter Xp11.23-p11.4 Xp11.1p11.22 Xp11.2→pter Xp22.33p22.13
IUGr/Gr + - - - - - - +
Facial 
dysmorphism
+ + + + + + + +
Hypertelorism - + - - - + + -
Ear 
abnormalities
- + + - - + + -




+ + + + + + + +
Hypotonia + - - + - + + -
Myoclonal 
seizures
+ + - + - - + -
Small hands and 
feet
- - + + - - - -
Clinodactyly - - + + - - + -
Digital clubbing + - - - - - - -
Hypermelanosis 
of Ito
- + - + - - - -
Foramen ovale 
apertum
- - - + - - + -
Hydronephrosis - - - + - - + -
Nystagmus + - - + - - - -
tachypnea - - - - - - - -
Supernummery 
nipple 
- - - - - - - -
Sacral 
Mongolian spot 




+ - - - - - + -
respiratory 
distress
+ +- - - - - - +
IUGR = intrauterine growth restriction; GR = growth restriction.
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Figure 1 Panels A–R: Meiotic outcomes of the proband’s mother’s balanced translocation. Panels A, B, K, and L are the 
most likely products (normal and balanced) from the proband’s mother’s reciprocal translocation. The Panel L outcome 
may result in infertility; Panel B may be associated with an abnormal clinical phenotype if the normal X chromosome 
is not preferentially inactivated; Panel C is known to be viable; Panel M would be expected to have the same degree 
of viability; Panel D is expected to have a less severe phenotype if the derivative X is preferentially inactivated. The 
outcomes shown in Panels E, G, I, J, O, and Q are known to be viable, and would be expected to show features of triple 
X, Turner syndrome or Klinefelter’s syndrome; however, Panels E, G, O, and Q may have a more severe phenotype if the 
normal X homologues are not inactivated. The outcome shown in Panel N is considered to be less viable and associated 
with a more severe phenotype. The outcomes shown in Panels F, H, P, and R would result in trisomy 13. Other modes of 
segregation would have larger imbalances that are considered more unlikely to be viable.
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Of those genes that lie outside the PAR1 
region of the maternal 17.2 Mb duplication in the 
proband, it is largely unclear which ones could have 
played a role in the proband’s clinical phenotype. 
Mutations in the KAL1 gene have been detected in 
patients diagnosed with Kallman syndrome,15–17 but 
overexpression of this protein in Caenorhabditis 
elegans induces axon branching and axon 
misrouting.18,19 In the case of the GRPR gene, Bolton 
et al. and Ishikawa-Brush et al. reported a female 
patient with a balanced translocation 46,X,t(X;8)
(p22.13;q22.1).20,21 The woman presented with 
multiple exostoses around the ankles, knees, wrists, 
and left clavicle. She was short, with small hands, 
mild brachycephaly, mental retardation, epilepsy, 
and autism. The translocation breakpoint on the X 
chromosome occurred in the first intron of the GRPR 
gene, which suggested that haploinsufficiency of the 
GRPR gene may have contributed to this patient’s 
phenotype. Interestingly, and in the context of the 
proband reported here, recent studies have shown 
that overexpression of GRPR in the chick brain leads 
to laminar disorganisation in the telencephalon, 
tectum, and particularly in the cerebellum, which 
exhibits severe atrophy.22 It is therefore tempting to 
suggest that overexpression of KAL1 and GRPR may 
underlie some aspects of the proband’s phenotype.
This case also highlights genetic counselling 
issues. Genetic counselling provided an opportunity 
to explain the proband’s karyotype abnormality 
to the parents, how it may have accounted for 
her phenotype, and to discuss recurrence risks. 
Establishing that the mother carried a de novo 
balanced translocation removed the need to counsel 
extended family members, but confirmed the need 
to explain to the couple the variety of possible 
outcomes in a future pregnancy.
At first glance, and given the overwhelming 
number of possible segregations [Figure 1; not all 
possible segregations are shown], a discussion 
about possible pregnancy outcomes would appear 
to be daunting. Practically, one way to approach 
such counselling may be to consider the outcomes 
by gender.
In female fetuses with a Turner, Turner 
variant, or trisomy 13 chromosome complement 
(segregation patterns I, J, F, and H, respectively), 
a high rate of spontaneous miscarriage is to be 
expected. The Turner variant of pattern D possibly 
carries a lower risk of abortion. Females with 
these genotypes who survive to delivery could be 
expected to have an abnormal phenotype: trisomy 
13 would carry the greater degree of morbidity and 
mortality. Females with greater or lesser degrees of 
trisomy X (segregation patterns C, E, and G) would 
be expected to survive to term and have a milder 
phenotype. These phenotypes, and those resulting 
from segregation pattern D, may be modified by 
unpredictable X chromosome inactivation, and 
may range from normal to the phenotype observed 
in the proband, or have more severe problems. The 
carrier mother could also have normal females 
(patterns A and B) though a female with pattern 
B may be affected, depending on X chromosome 
inactivation.
In male fetuses, one would expect those with 
segregation patterns N, P, and R to have a high 
risk of spontaneous abortion. Patterns P and R 
result in trisomy 13 and, for pattern N, some of 
the genes in the deleted Xp region cause X-linked 
dominant conditions which are lethal in males 
in the hemizygous state. Certainly, some males 
with trisomy 13 may survive to birth. Males with 
segregation patterns O and Q would be expected to 
have a Klinefelter’s syndrome phenotype, although 
those with pattern Q could manifest additional 
rare X-linked dominant conditions not usually 
seen in males. Infertility may be part of some 
phenotypes, but would possibly only be clinically 
relevant in males with pattern L. It is difficult to 
predict the clinical outcome of pattern M (partial 
duplication of Xp22.3p22.13). Given the number of 
OMIM genes in the region, a range of possibilities 
(from normal to affected) could be considered. 
Of relevance in terms of the latter outcome is a 
report of a male with a mild learning disability 
and the karyotype 46,Xdup(X)(p22.13-p22.31),Y.23 
Tzschach et al. provide a summary of male mental 
retardation patients with a duplication or disomy 
of Xp22.24 Critically, the challenge in counselling 
is the characterisation of patients with smaller 
duplications than those reported to date that could 
provide a better insight into those genes that play a 
significant role in mental retardation.
Genetic counselling was greatly aided in 
this case by the identification of the exact 
breakpoints and genes involved in the chromosome 
rearrangement in the mother of the proband. For 
almost all the segregation patterns, fairly clear 
information can be conveyed to the parents about 
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the expected outcome or phenotype. This would 
aid in reproductive decision-making, either before 
or during a future pregnancy. The case illustrates 
how patient care benefits from close collaboration 
between clinicians and the laboratory.
Conclusion
Carriers of balanced translocations involving the 
X chromosome offer challenges in terms of genetic 
counselling; however, delineation of the breakpoints 
of the rearranged chromosomes can aid the clinician 
in their conversations with carriers in the context of 
reproductive decision-making.
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